SCHEMBL1027476

SCHEMBL1027476

Cc1cn(C)c(C(=O)NC2CCc3ccccc32)c1-c1ccco1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
HSD17B10 Q99714 2/20 0.47
TAS1R3 Q7RTX0 6/20 0.45
TAS1R1 Q7RTX1 6/20 0.45
TAS1R2 Q8TE23 4/20 0.45
PDE2A O00408 1/20 0.45
RECQL P46063 2/20 0.43
CHRM4 P08173 2/20 0.43
KDM4E B2RXH2 1/20 0.43
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1027475 0.82 NPC1 (0.44) HSD17B10RECQLCHRM4KDM4ELMNA
SCHEMBL1031744 0.80 NPC1 (0.49) ALDH1A1HSD17B10RECQLKDM4ELMNA
SCHEMBL1031680 0.79 HPGDS (0.48) ALDH1A1TAS1R3TAS1R1TAS1R2PDE2A
SCHEMBL1032244 0.76 ALDH1A1 (0.54) ALDH1A1HSD17B10TAS1R3TAS1R1TAS1R2
SCHEMBL1032220 0.74 RAB9A (0.47) ALDH1A1HSD17B10KDM4EHTTLMNA
SCHEMBL22729721 0.69 PDE2A (0.51) ALDH1A1HSD17B10TAS1R3TAS1R1TAS1R2
SCHEMBL5969897 0.69 TAS1R3 (0.64) ALDH1A1HSD17B10TAS1R3TAS1R1TAS1R2
SCHEMBL6319067 0.69 RECQL (0.51) ALDH1A1HSD17B10TAS1R3TAS1R1TAS1R2
SCHEMBL1031516 0.68 LMNA (0.54) ALDH1A1HSD17B10KDM4ETSHRHTT
SCHEMBL929418 0.68 ADORA2A (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968591-B2 1,3-disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their use in medicaments GRUENENTHAL GMBH (DE) 2011-06-28 US claimed
EP-2035375-B1 1,3-DISUBSTITUTED 4-METHYL-1H-PYRROLE-2-CARBOXAMIDES AND THEIR USE FOR THE MANUFACTURE OF MEDICAMENTS GRUENENTHAL GMBH (DE) 2011-01-19 EP claimed
US-20090137573-A1 1,3-Disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their Use in Medicaments GRUENENTHAL GMBH (DE) 2009-05-28 US claimed
US-7968591-B2 1,3-disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their use in medicaments GRUENENTHAL GMBH (DE) 2011-06-28 US disclosed
US-20090137573-A1 1,3-Disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their Use in Medicaments GRUENENTHAL GMBH (DE) 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137573-A1 1,3-Disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their Use in Medicaments OPRL1, TPH1, OPRK1 ALDH1A1 2168/4885HSD17B10 3763/4885TAS1R3 1688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.